• About
    • About Us
    • What We Cover
  • Advertise
    • Advertise
    • Our Advertisers
  • Contact
  • Donate
  • Send News
  • Subscribe

Oak Ridge Today

  • Home
  • Sign in
  • News
    • Business
    • Community
    • Education
    • Government
    • Health
    • Police and Fire
    • U.S. Department of Energy
    • Weather
  • Sports
    • High School
    • Middle School
    • Recreation
    • Rowing
    • Youth
  • Entertainment
    • Arts
    • Dancing
    • Movies
    • Music
    • Television
    • Theater
  • Premium Content
  • Obituaries
  • Classifieds




Updated: TerraPower, Isotek extracting cancer treatment materials from U-233 at ORNL

Posted at 11:50 am November 22, 2019
By John Huotari Leave a Comment

DOE EM ORNL Pumping Uranyl Nitrate Solution into Resin Columns
TerraPower, a company that Microsoft co-founder Bill Gates helped launch in 2006, is working with Isotek Systems LLC, a federal cleanup contractor in Oak Ridge, to extract rare isotopes from nuclear materials for cancer treatment and research. Pictured above is a uranyl nitrate solution being pumped into resin columns. (Photo courtesy U.S. Department of Energy Oak Ridge Office of Environmental Management)

Note: This story was last updated at 10:30 a.m. Nov. 25.

A company that Microsoft co-founder Bill Gates helped launch in 2006 is working with a federal cleanup contractor in Oak Ridge to extract rare isotopes from nuclear materials for cancer treatment research.

The project will significantly increase the number of cancer treatment doses available each year, federal officials and company executives said Friday. It will help remove highly enriched fissile nuclear material from Oak Ridge National Laboratory and save taxpayers an estimated $90 million, the officials and executives said. And it will recycle an isotope that would otherwise be “irretrievably lost” as the nuclear material, uranium-233, is converted into a disposal-ready form.

The U.S. Department of Energy, Isotek Systems LLC, and TerraPower celebrated with an announcement of the project in Oak Ridge on Friday morning.

TerraPower, which is based in Bellevue, Washington, where Gates is chairman, is particularly interested in actinium-225. That isotope can be extracted from thorium-229. The thorium will be removed from the fissile material, the uranium-233 stored at ORNL, by the federal cleanup contractor, Isotek.

The unique agreement, a public-private partnership, is expected to allow TerraPower the ability to make 100 times more actinium-225-based cancer treatment doses per year than the 4,000 doses that are currently available worldwide. TerraPower could first offer actinium-225 in late 2020, company executives said.

“As a nuclear innovation company, TerraPower seeks work that is both challenging and of great importance to humankind,” said TerraPower President and Chief Executive Officer Chris Levesque. “We are excited to partner on this effort and expect positive health outcomes as a result.”

TerraPower and Isotek reached an agreement about a year ago, and their partnership could last about five years. The extraction of the thorium-229 began this fall.

Advertisement

Isotek has a contract with the U.S. Department of Energy to remove the uranium-233 (U-233) stored in Building 3019, a 1940s-era building at ORNL. Isotek will remove the thorium-229 from the U-233 and sell the thorium to TerraPower. The U-233 that remains will be disposed of at a site designated by DOE.

“It’s an exciting thing for us to clean up legacy material and save a rare isotope for potential cancer treatment,” said Isotek President Jim Bolon, who is also the project manager.

TerraPower expects to purchase about 40 to 45 grams of the thorium during a five-year period. That would be enough for about 500,000 doses per year, virtually forever, the company said. (Thorium-229 has a half-life of close to 8,000 years.)

“The thorium-229 is exceedingly valuable for medical purposes,” said Sandy Taylor, president of SNC-Lavalin’s global nuclear sector. SNC-Lavalin is a parent company of Isotek.

The thorium will be shipped in shielded containers transported by truck from Oak Ridge to TerraPower’s laboratory in Everett, Washington, north of Seattle, where the actinium-225 will be extracted. About 100 shipments are expected.

TerraPower received its first small milligram-sized batch of thorium-229 last Wednesday, the company’s senior vice president of innovation, Jeff Latkowski, said Friday. Separating the thorium from the uranium that remains in what is essentially a smudge inside a vial could begin in the spring of 2020, Latkowski said. TerraPower hopes to provide actinium for research and development to biotech firms and pharmaceutical companies in the second half of 2020.

“TerraPower intends to provide material primarily to the R&D (research and development) and pharmaceutical communities for drug development,” a company fact sheet said. “If drug development is successful, then larger quantities will be needed.”

TerraPower wants to extract actinium-225 from thorium-229, a byproduct of the decay of uranium-233, for use in cancer treatment research.

Federal officials and company executives said alpha-emitting isotopes such as actinium-225 could be used to treat prostate, acute myeloid leukemia, colorectal, and other cancers. “The short range of the alphas means that, if well targeted, treatment would be more effective with less damage to healthy tissue,” the fact sheet said. The potential use of alpha particles is still a relatively new science, and actinium-225 is not yet approved for use in the United States. But officials suggested its targeted nature could mean that it would compare favorably to chemotherapy, an existing cancer treatment that has side effects that cause people to lose their hair and feel bad.

“This is a much more targeted approach,” Levesque said.

Trials of actinium in other countries have shown promising results, Levesque said, but more research is needed in the United States, along with approval by the U.S. Food and Drug Administration.

Levesque said TerraPower has been studying what it calls targeted alpha therapy since 2013, and Friday’s celebration was the culmination of about five years of work.

He said the actinium-225 could be provided for what are known as monoclonal antibodies. TerraPower describes those as “heat-seeking missiles of cancer treatment” that can target proteins expressed by cancers. Levesque said the actinium would be like the payload, and the monoclonal antibodies would be like the truck that delivers the payload.

He said the amount that TerraPower will pay Isotek for the thorium is confidential, but it is in the range of millions of dollars. A fact sheet distributed at Friday’s announcement said TerraPower is paying a reasonable price for materials that don’t currently have a market.

DOE EM ORNL Fissionable Material Handlers Opening U-233 Canister
TerraPower, a company that Microsoft co-founder Bill Gates helped launch in 2006, is working with Isotek Systems LLC, a federal cleanup contractor in Oak Ridge, to extract rare isotopes from nuclear materials for cancer treatment and research. Pictured above are fissionable material handlers opening a uranium-233 canister. (Photo courtesy U.S. Department of Energy Oak Ridge Office of Environmental Management)

Isotek will use the money from the sale of the thorium-229 to pay for part of the project to dispose of the uranium-233 at ORNL.

“This approach allows down blending operations to begin a year ahead of schedule, accelerates the overall project schedule, and saves approximately $90 million taxpayer dollars,” federal officials and company executives said in a press release Friday.

The private funding of part of the cleanup project means DOE now expects to complete all processing operations of uranium-233 in 2025, the fact sheet said.

“Eliminating this inventory from storage will avoid sizable costs for DOE annually, benefiting taxpayers,” it said.

Besides Levesque and Bolon, other speakers at Friday’s celebration were DOE Deputy Under Secretary for Science Thomas L. Cubbage III, DOE Senior Advisor for Environmental Management to the Under Secretary for Science William “Ike” White, U.S. Senator Marsha Blackburn, and U.S. Representative Chuck Fleischmann.

“This is a waste product that is now going to be used to treat people with cancer,” said Fleischmann, whose district includes Oak Ridge.

Advertisement

About half of the uranium-233 (U-233) stored at ORNL has been transferred and disposed of, according to Friday’s press release. Oak Ridge Today reported two years ago, in November 2017, that about half of the U-233 stored in Building 3019 at ORNL had been shipped to Nevada National Security Site, a former nuclear weapons proving ground about 65 miles northwest of Las Vegas. That included waste from the Consolidated Edison Uranium Solidification Program, or CEUSP.

Other U-233 waste stored in secure vaults in Building 3019 at ORNL has included materials from glovebox research at ORNL, reactor plates, and conglomerate waste. Officials have previously said at least some of that waste will be treated, or “downblended,” at Building 2026, across the street from Building 3019. The DOE Oak Ridge Office of Environmental Management owns both buildings.

Removing the U-233 is the top-priority cleanup project at ORNL because, among other things, storing it at the lab increases security costs and creates nuclear safety issues. Building 3019 is the oldest operating nuclear facility in the world, according to DOE.

The remaining inventory of U-233 has to be processed and down blended before it can be disposed of. The processing of the remaining inventory began in the fall of 2019, and it is expected to be finished in 2024. The waste, which is stored in canisters, will be divided into smaller batches, blended with a weakened solution to lower the radiation dose, and mixed with concrete and shipped for low-level waste disposal.

Istotek recently began extracting thorium from the uranium-233 at ORNL, according to a video posted online by DOE. The thorium is extracted before the U-233 is down blended.

Extracting the thorium from the uranium involves three glove boxes, which were purchased using the private funding, according to DOE. Glove boxes are sealed chambers with windows where workers can insert their hands into gloves and work remotely with nuclear materials inside the box.

DOE EM ORNL Fissionable Material Handlers Working in Glovebox
TerraPower, a company that Microsoft co-founder Bill Gates helped launch in 2006, is working with Isotek Systems LLC, a federal cleanup contractor in Oak Ridge, to extract rare isotopes from nuclear materials for cancer treatment and research. Fissionable material handlers work in a glovebox above. (Photo courtesy U.S. Department of Energy Oak Ridge Office of Environmental Management)

After being split into samples in one glove box, the uranium is mixed with nitric acid in a second to create a uranyl nitrate solution. It is pumped through two columns to remove first plutonium and then thorium using extraction resins. The uranyl nitrate that remains is pumped into a reservoir and put into a drum for disposal.

The thorium is removed from the extraction resin using a lower concentration nitric acid. It is then separated from the nitric acid in the third glove box, where the nitric acid is evaporated over a water bath, leaving about 70 milligrams of thorium.

A parallel process will be used to extract the actinium from the thorium in TerraPower’s lab in Everett, said Latkowski, the TerraPower senior vice president of innovation. A radioisotope generator could have something to attract thorium in a column. The thorium will decay to radium-225, which has a 15-day life, and actinium-225, which has a 10-day half life, Latkowski said. Those isotopes, which may not be attracted to the material that attracts the thorium in the column, could be flushed out with a solution.

Thorium-229 is an isotope generated by the decay of uranium-233. Uranium-233 is a radioactive isotope of uranium that does not exist in nature, but it can be produced by bombarding thorium-232 with neutrons. It was created as an additional fuel source for nuclear reactors in case uranium-235 ran out. But U-233 proved to be unviable as a fuel source because its creation generated uranium-232, a highly unstable radioactive isotope.

DOE EM ORNL Thorium Extract
TerraPower, a company that Microsoft co-founder Bill Gates helped launch in 2006, is working with Isotek Systems LLC, a federal cleanup contractor in Oak Ridge, to extract rare isotopes from nuclear materials for cancer treatment and research. A thorium extract is pictured above. (Photo courtesy U.S. Department of Energy Oak Ridge Office of Environmental Management)

Bolon, of Isotek, said about two tons of uranium-233 were produced in the 1950s and early 1960s. U-232 decays to thalium-208, which emits high-energy gamma rays, Bolon said. Most of the uranium at ORNL has uranium-232 in it, so workers will use areas known as “hot cells,” which have more shielding and where workers can manipulate hazardous materials remotely with mechanical arms.

Bolon said the hot cells are being outfitted and processing could start in about a year.

More than 500 canisters of U-233 remain, mostly as uranium oxide but also in metal and ceramic monoliths. There are also sodium fluoride traps from the Molten Salt Reactor Experiment at ORNL, where uranium-233 fluoride salt and other fuels were tested.

About 60 canisters of Oak Ridge Oxide that were produced here can be processed in glove boxes, and that processing work will continue in the meantime, Bolon said.

The U.S. Department of Energy Office of Environmental Management announced in October that workers had started processing the U-233 powder in glove boxes a year ahead of schedule.

See our previous stories on uranium-233 here.

The image above describes how and why uranium-233 was produced and why it is no longer being used.
Isotek Systems LLC is the U.S. Department of Energy contractor responsible for disposing of the uranium-233 stored at Oak Ridge National Laboratory. The image above describes the disposal.
The uranium-233 is stored in Building 3019 at Oak Ridge National Laboratory. Building 3019 is the oldest continuously operating nuclear facility in the world, according to the U.S. Department of Energy.
Uranium-233 will be “down blended” in Building 2026 at Oak Ridge National Laboratory.

More information will be added as it becomes available.

You can contact John Huotari, owner and publisher of Oak Ridge Today, at (865) 951-9692 or [email protected]

Most news stories on Oak Ridge Today are free, brought to you by Oak Ridge Today with help from our advertisers, sponsors, and subscribers. This is a free story. Thank you to our advertisers, sponsors, and subscribers. You can see what we cover here.


Do you appreciate this story or our work in general? If so, please consider a monthly subscription to Oak Ridge Today. See our Subscribe page here. Thank you for reading Oak Ridge Today.

Copyright 2019 Oak Ridge Today. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Filed Under: Business, DOE, Oak Ridge, Oak Ridge National Laboratory, Oak Ridge Office of Environmental Management, Slider Tagged With: actinium-225, alpha particles, alpha-emitting isotope, Atkins, Bill Gates, Building 3019, cancer treatment, Chris Levesque, Chuck Fleischmann, DOE, Isotek Systems LLC, isotope, Jay Mullis, Jeff Latkowski, Jim Bolon, monoclonal antibodies, Oak Ridge National Laboratory, Oak Ridge Office of Environmental Management, ORNL, Sandy Taylor, SNC-Lavalin, TerraPower, thorium-229, U.S. Department of Energy, uranium-233

Advertisements

 

Join the club!

If you appreciate our work, please consider subscribing. Besides helping us, your subscription will give you access to our premium content.

Most of our stories are free, brought to you by Oak Ridge Today with help from our members—advertisers, subscribers, and sponsors.

But some are premium content, available only to members. Those are in-depth, investigative, or exclusive stories that are available only on Oak Ridge Today. They generally require at least four hours to report, write, and publish.

You can subscribe for as little as $5 per month.

You can read more about your options here.

We currently offer five primary subscription options to readers, and they include benefits.

Basic

  • Basic monthly subscription ($5 per month)—access premium content
  • Basic annual subscription ($60 per year)—access premium content

Pro

  • Pro monthly subscription ($10 per month)—access premium content, get breaking news emails first, and submit one press release or public service announcement per month
  • Pro annual subscription ($100 per year)—save $20 per year, access premium content, get breaking news emails first, and submit one press release or public service announcement per month

Temporary

  • Temporary access ($3 per week for two weeks)

We also have advanced subscription options. You can see them here.

We also accept donations. You can donate here.

If you prefer to send a check for a subscription or donation, you may do so by mailing one to:

Oak Ridge Today
P.O. Box 6064
Oak Ridge, TN 37831

Thank you for your consideration and for reading Oak Ridge Today. We appreciate your support.

Commenting Guidelines

We welcome comments, but we ask you to follow a few guidelines:

1) Please use your real name, including last name. Please also use a valid e-mail address.
2) Be civil. Don't insult others, attack their character, or get personal.
3) Stick to the issues.
4) No profanity.
5) Keep your comments to a reasonable length and to a reasonable number per article.

We reserve the right to remove any comments that violate these guidelines. Comments held for review, usually from those posting for the first time, may not post if they violate these guidelines. Thank you for your patience and understanding. Thank you also for reading Oak Ridge Today and for participating in the discussion.

More information is available here.

More Business News

Update on downtown Oak Ridge Tuesday

A city official will give an update on the proposed development of downtown Oak Ridge during a lunchtime meeting Tuesday. The presentation will be led by Wayne Blasius, director of the Oak Ridge Planning and … [Read More...]

CROET president tells Oak Ridge story on national podcast

Teresa Frady, president of the Community Reuse Organization of East Tennessee, is the Spotlight Interview guest on this week’s episode of the Gone Fission Nuclear Report podcast, which covers U.S. Department of … [Read More...]

Willow Ridge Garden Center named small business of month

  Willow Ridge Garden Center has been named the Oak Ridge Chamber of Commerce's Small Business of the Month for February 2022. The award is sponsored by Enrichment Federal Credit Union. Willow Ridge Garden Center is … [Read More...]

Frady named CROET president, CEO

Teresa Frady has been named president and chief executive officer of the Community Reuse Organization of East Tennessee. CROET is a regional economic development nonprofit organization that helps find new uses for … [Read More...]

3M expanding in Clinton

The 3M Company plans to expand in Clinton, investing about $470 million and adding around 600 new jobs by 2025, a press release said. The expansion was announced Thursday by Tennessee Governor Bill Lee, Department of … [Read More...]

More Business

Recent Posts

  • Rocky Top woman pleads guilty to murder, sentenced to life
  • REAC/TS welcomes new team members: John Crapo, Josh Hayes and David Quillen
  • NASA Postdoctoral Program seeks early career and senior scientists for prestigious fellowships at its locations across the U.S.
  • ORAU names Brandon Criswell associate general counsel
  • Update on downtown Oak Ridge Tuesday
  • TVA has virtual open house for Clinch River Nuclear Site
  • Science and supercomputers at ORNL topic of Mar. 8 talk
  • First Presbyterian offers free meals & groceries on Mar. 10
  • Secret City Academy student charged with terrorism after alleged shooting, bomb threats
  • ORHS Masquers presents ‘Into the Woods’

Search Oak Ridge Today

About Us

About Oak Ridge Today
What We Cover

How To

Advertise
Subscribe

Contact Us

Contact Oak Ridge Today

Copyright © 2022 Oak Ridge Today